| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.003 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |